RCG
ABBV icon

Rock Creek Group’s AbbVie ABBV Stock Holding History

Rock Creek Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,623
Closed -$242K – 63
2023
Q3 		$242K Sell
1,623
-464
-22% -$68.1K 0.03% 78
2023
Q2 		$281K Sell
2,087
-451
-18% -$66.1K 0.04% 81
2023
Q1 		$404K Sell
2,538
-77
-3% -$11.8K 0.05% 73
2022
Q4 		$423K Sell
2,615
-61
-2% -$9.35K 0.05% 65
2022
Q3 		$359K Buy
2,676
+195
+8% +$28K 0.05% 69
2022
Q2 		$380K Sell
2,481
-853
-26% -$130K 0.04% 72
2022
Q1 		$540K Buy
3,334
+1,354
+68% +$197K 0.07% 65
2021
Q4 		$268K Buy
1,980
+111
+6% +$13.1K 0.04% 124
2021
Q3 		$202K Sell
1,869
-1,660
-47% -$190K 0.03% 103
2021
Q2 		$398K Buy
3,529
+853
+32% +$96.1K 0.06% 102
2021
Q1 		$290K Sell
2,676
-1,876
-41% -$201K 0.05% 101
2020
Q4 		$488K Sell
4,552
-4,463
-50% -$429K 0.2% 88
2020
Q3 		$790K Buy
9,015
+1,943
+27% +$183K 0.41% 64
2020
Q2 		$694K Buy
+7,072
New +$623K 0.37% 60

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rock Creek Group's ABBV Position: Q4 2023 in Review

Rock Creek Group sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,623 shares — an estimated $242K sold.

Rock Creek Group first reported a position in ABBV in Q2 2020 and held it in 14 quarters. The position peaked at $790K in Q3 2020. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Rock Creek Group reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 1,623 AbbVie shares in Q4 2023, an estimated $242K.
  • Rock Creek Group first reported a position in AbbVie in Q2 2020 and held it in 14 quarters.
  • Rock Creek Group's AbbVie position peaked at $790K in Q3 2020.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.